Aardvark Therapeutics Inc
(AARD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AARD | AZN | AMGN | GILD | VRTX |
| Company | Aardvark Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.84 | 187.50 | 339.47 | 141.05 | 466.79 |
| High | 13.66 | 192.79 | 345.98 | 143.80 | 473.74 |
| Low | 12.80 | 186.18 | 339.41 | 140.01 | 464.01 |
| Latest | 13.30 | 188.41 | 344.68 | 142.89 | 472.01 |
| Change | +0.31 | +1.31 | +2.80 | +0.94 | +2.11 |
| % Change | +2.39% | +0.70% | +0.82% | +0.66% | +0.45% |
| Volume | 151,800 | 3,228,700 | 1,899,800 | 6,898,200 | 759,700 |
| 20-Day Average Volume | 187,375 | 9,430,835 | 2,766,525 | 7,869,025 | 1,530,345 |
| Previous Close | 12.99 | 187.10 | 341.88 | 141.95 | 469.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.44 | 98.24 | 336.36 | 129.18 | 463.27 |
| 20-Day Raw Stochastic | 20.94% | 95.78% | 75.54% | 96.62% | 73.50% |
| 20-Day Relative Strength | 46.93 | 91.25 | 57.80 | 70.20 | 57.07 |
| Weighted Alpha | -32.31 | +68.67 | +21.88 | +52.06 | +6.15 |
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 56% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.89% since 01/26/26 | +99.95% since 01/26/26 | -1.43% since 01/26/26 | +3.71% since 01/26/26 | -1.01% since 01/26/26 |
| Low | 12.43 on 01/30/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 137.54 on 01/27/26 | 464.01 on 02/02/26 |
| High | 15.11 on 01/28/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | +0.83% since 01/02/26 | +105.76% since 01/02/26 | +5.20% since 01/02/26 | +17.51% since 01/02/26 | +4.40% since 01/02/26 |
| Low | 12.43 on 01/30/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 16.60 on 01/22/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +24.42% since 10/31/25 | +128.65% since 10/31/25 | +15.50% since 10/31/25 | +19.28% since 10/31/25 | +10.91% since 10/31/25 |
| Low | 8.82 on 11/21/25 | 80.48 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 403.16 on 11/04/25 |
| High | 16.60 on 01/22/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +9.65% since 08/01/25 | +154.78% since 08/01/25 | +16.10% since 08/01/25 | +26.25% since 08/01/25 | +2.14% since 08/01/25 |
| Low | 7.50 on 09/11/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 17.94 on 10/08/25 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 143.80 on 02/02/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,831 | 287,755,456 | 184,095,904 | 176,114,528 | 119,222,552 |
| Shares Outstanding, K | 21,773 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -20,590,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -16,320,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | N/A | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.75 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/30/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.26 | 15.68 | 17.04 | 31.07 |